Pura Vida Investments’s Lyra Therapeutics LYRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-28,265
Closed -$8.79M 46
2024
Q1
$8.79M Hold
28,265
1.48% 5
2023
Q4
$7.41M Hold
28,265
1.13% 4
2023
Q3
$5.53M Hold
28,265
1.05% 12
2023
Q2
$5.72M Sell
28,265
-11,674
-29% -$2.36M 0.76% 13
2023
Q1
$4.01M Sell
39,939
-3,207
-7% -$322K 0.41% 24
2022
Q4
$6.77M Sell
43,146
-7,060
-14% -$1.11M 0.35% 22
2022
Q3
$12.6M Sell
50,206
-1,318
-3% -$330K 0.73% 12
2022
Q2
$14.6M Buy
51,524
+41,113
+395% +$11.6M 0.85% 12
2022
Q1
$2.09M Buy
10,411
+66
+0.6% +$13.3K 0.07% 61
2021
Q4
$2.26M Sell
10,345
-323
-3% -$70.4K 0.08% 63
2021
Q3
$4.87M Sell
10,668
-185
-2% -$84.4K 0.15% 73
2021
Q2
$4.36M Buy
+10,853
New +$4.36M 0.14% 78
2020
Q4
Sell
-4,534
Closed -$2.54M 159
2020
Q3
$2.54M Buy
4,534
+574
+14% +$321K 0.13% 65
2020
Q2
$2.25M Buy
+3,960
New +$2.25M 0.22% 56